A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients | Zendy

Donald Hsu | Zendy; M. Hong Nguyen | Zendy; Long H. Nguyen | Zendy; Anandi V. Law | Zendy; Annie WongBeringer | Zendy

Open Access

A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients

Author(s) -

Donald Hsu,

M. Hong Nguyen,

Long H. Nguyen,

Anandi V. Law,

Annie WongBeringer

Publication year - 2010

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkq216

Subject(s) - caspofungin , invasive candidiasis , medicine , echinocandins , echinocandin , pathogenic organism , intensive care medicine , antifungal , voriconazole , fluconazole , biology , microbiology and biotechnology , dermatology

Candida non-albicans species cause an increasing proportion of invasive candidiasis (IC). Prompt initiation of effective antifungal therapy has been shown to positively impact the outcomes of IC. Caspofungin is often reserved as a second-line agent after suboptimal response to initial therapy. We determined the impact of the timing of caspofungin administration on outcomes of IC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research